Fenofibrate slows diabetic retinopathy progression in at-risk patients

Fenofibrate slows diabetic retinopathy progression in at-risk patients

Intensive treatment of glycemia and dyslipidemia slowed the progression of diabetic retinopathy in diabetic patients with cardiovascular disease or associated risk factors, according to study findings.

  • Data were culled from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study, a collection of three randomized clinical trials designed to evaluate the effects of intensive blood…

View On WordPress

Text
Photo
Quote
Link
Chat
Audio
Video